.png){kind=icon}
Junxuan Lu (Junxuan Lü)
H指数:56
被引数:8,451
个人简介
A Professor of Neuroscience and Experimental Therapeutics effective February 1, 2025, and has served as Professor of Pharmacology since November 2015, holding the Bernard B. Brodie professor title since 2023. Previously, the scholar was a professor of Biomedical Sciences and department chairperson at Texas Tech University School of Pharmacy in Amarillo, Texas (2011-2015), and served as Associate and full professor of Cancer Biology at the Hormel Institute, University of Minnesota (2002-2011). Prior to that, the scholar conducted mammary carcinogenesis and chemoprevention research at AMC Cancer Research Center, Denver, CO (1992-2002). Current research focuses on natural products and compounds, including preclinical studies and human clinical trials, with discoveries related to pyranocoumarins from Korean angelica root as novel anti-androgens and assessments of angelica extracts for anti-cancer efficacy, tissue distribution, and metabolic impacts. The scholar has completed the first-in-human PK study of pyranocoumarins and is conducting early-stage clinical trials in prostate cancer patients. Additionally, research explores selenium-based next-gen synthetic entities for cancer chemoprevention, defining clinically relevant forms and assessing their in vivo efficacy in animal models.
教育背景
暂无内容
工作经历
2011.01 – 2015.12
Texas Tech University School of Pharmacy
2011.01 – 2014.12
Texas Tech University School of Pharmacy
Department Chairperson
2002.01 – 2011.12
Hormel Institute, University of Minnesota
Associate and full professor of Cancer Biology
1992.01 – 2002.12
AMC Cancer Research Center
荣誉奖项
暂无内容
药物抵抗性胶质母细胞瘤中的半胱氨酸成瘾及利用设计型硒化合物的治疗靶向
Neuro-Oncology
IF13.4
FASEB JOURNAL
IF4.2
CARCINOGENESIS
IF2.9
CHEMMEDCHEM
IF3.4
ANNALS OF ONCOLOGY
IF65.4
CANCER RESEARCH
IF16.6
CANCER RESEARCH
IF16.6
CANCER RESEARCH
IF16.6
CANCER RESEARCH
IF16.6
CANCER RESEARCH
IF16.6
CANCER RESEARCH
IF16.6
